Is airduo for copd?

What Is AirDuo Digihaler for COPD?

AirDuo Digihaler is a prescription inhalation medication used to treat chronic obstructive pulmonary disease (COPD) symptoms, including shortness of breath and coughing. It combines an inhaled corticosteroid (fluticasone) and a long-acting beta2-adrenergic agonist (salmeterol) to help control and prevent symptoms.

How Does AirDuo Work?

AirDuo Digihaler works by relieving inflammation and constriction in the airways, making it easier to breathe. The medication is delivered directly to the lungs through inhalation, reducing the risk of systemic side effects.

[1] DrugPatentWatch.com (https://www.drugpatentwatch.com/)

What Are the Benefits of AirDuo?

Benefits of AirDuo Digihaler include improved lung function, reduced symptoms, and enhanced quality of life. Clinical trials have shown that AirDuo is effective in managing moderate to severe COPD symptoms.

[2] American Lung Association (https://www.lung.org/)

Who Is a Candidate for AirDuo?

AirDuo Digihaler is approved for use in adults with COPD, including global initiative for chronic obstructive lung disease (GOLD) stages II-IV. Patients with a history of asthma, heart conditions, or other medical conditions should consult their doctor to determine if AirDuo is suitable for them.

Potential Side Effects and Precautions

Common side effects of AirDuo Digihaler include oral thrush, cough, and bronchitis. More serious side effects can occur, such as serious allergic reactions, high blood sugar, and cardiovascular problems. Patients should inform their doctor about any medications or medical history before taking AirDuo.

[3] FDA.gov (https://www.fda.gov/)

How to Use AirDuo Digihaler Responsibly

It's essential to follow your doctor's instructions when using AirDuo Digihaler, and to use the medication as directed. Proper use includes priming the inhaler, taking it at the same times each day, and rinsing the mouth after use.

Patent Expiration for AirDuo Digihaler

AirDuo Digihaler is a branded inhaler with a limited patent life. As a result, a generic version may become available in the future, providing an alternative option for patients and potentially impacting the medication's cost and availability.

Sources:

1. DrugPatentWatch.com
2. American Lung Association
3. FDA.gov